These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2681 related articles for article (PubMed ID: 28689518)

  • 21. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 23. Controversies in colorectal cancer screening.
    Pox CP
    Digestion; 2014; 89(4):274-81. PubMed ID: 25034478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer screening: An updated review of the available options.
    Issa IA; Noureddine M
    World J Gastroenterol; 2017 Jul; 23(28):5086-5096. PubMed ID: 28811705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
    Daniels K; McKee M
    J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies in screening for colon carcinoma.
    de Wijkerslooth TR; Bossuyt PM; Dekker E
    Neth J Med; 2011 Mar; 69(3):112-9. PubMed ID: 21444935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
    Peterse EFP; Meester RGS; Siegel RL; Chen JC; Dwyer A; Ahnen DJ; Smith RA; Zauber AG; Lansdorp-Vogelaar I
    Cancer; 2018 Jul; 124(14):2964-2973. PubMed ID: 29846933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effectiveness of screening strategies for colorectal cancer.
    Barzi A; Lenz HJ; Quinn DI; Sadeghi S
    Cancer; 2017 May; 123(9):1516-1527. PubMed ID: 28117881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and current trends of colorectal malignancies in an unscreened, low risk Pakistan population.
    Bhurgri Y; Khan T; Kayani N; Ahmad R; Usman A; Bhurgri A; Bashir I; Hasan SH; Zaidi S
    Asian Pac J Cancer Prev; 2011; 12(3):703-8. PubMed ID: 21627368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
    Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal Strategies for Colorectal Cancer Screening.
    Jain S; Maque J; Galoosian A; Osuna-Garcia A; May FP
    Curr Treat Options Oncol; 2022 Apr; 23(4):474-493. PubMed ID: 35316477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer screening.
    Bretthauer M
    J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physician barriers to population-based, fecal occult blood test-based colorectal cancer screening programs for average-risk patients.
    McGregor S; Hilsden R; Yang H
    Can J Gastroenterol; 2010 Jun; 24(6):359-64. PubMed ID: 20559577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.
    Salimzadeh H; Bishehsari F; Sauvaget C; Amani M; Hamzehloo G; Nikfarjam A; Merat S; Delavari A; Malekzadeh R
    Arch Iran Med; 2017 Dec; 20(12):726-733. PubMed ID: 29664311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria.
    Jahn B; Sroczynski G; Bundo M; Mühlberger N; Puntscher S; Todorovic J; Rochau U; Oberaigner W; Koffijberg H; Fischer T; Schiller-Fruehwirth I; Öfner D; Renner F; Jonas M; Hackl M; Ferlitsch M; Siebert U;
    BMC Gastroenterol; 2019 Dec; 19(1):209. PubMed ID: 31805871
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 135.